Oncology & Cancer

Calculating leukemia progression

A new computational study published in the International Journal of Bioinformatics Research and Applications has shown how mutations that give rise to drug resistance occur in a form of cancer known as acute myeloid leukemia ...

Medications

Anticancer drugs: A new hope for sepsis treatment

The body's extreme response to infection, a condition called sepsis, kills 11 million people every year. This is because to survive a serious infection it is not enough to get rid of the infectious agent, which is currently ...

Oncology & Cancer

PXR: A stepping stone from environmental chemical to cancer?

Several chemicals that can accumulate to high levels in our body (for example BPA and some pesticides) have been recently linked to an increased risk of cancer and/or impaired responsiveness to anticancer drugs. A team of ...

Medications

Treating tough tumors by exploiting their iron 'addiction'

Researchers at the University of California, San Francisco, have successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account ...

Biomedical technology

Plug-and-play organ-on-a-chip can be customized to the patient

Engineered tissues have become a critical component for modeling diseases and testing the efficacy and safety of drugs in a human context. A major challenge for researchers has been how to model body functions and systemic ...

Oncology & Cancer

Repurposing nitroglycerin for anti-cancer treatments

For over a century, nitroglycerin has been used medically – particularly in the treatment of angina, or chest pain. It is a safe, cheap and effective treatment. Now, according to the latest study in ecancermedicalscience, ...

page 6 from 15